Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Molecular sequelae of proteasome inhibition in human multiple myeloma cells.
Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Fanourakis G, Gu X, Bailey C, Joseph M, Libermann TA, Treon SP, Munshi NC, Richardson PG, Hideshima T, Anderson KC. Mitsiades N, et al. Among authors: fanourakis g. Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14374-9. doi: 10.1073/pnas.202445099. Epub 2002 Oct 21. Proc Natl Acad Sci U S A. 2002. PMID: 12391322 Free PMC article.
The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications.
Mitsiades N, Mitsiades CS, Richardson PG, Poulaki V, Tai YT, Chauhan D, Fanourakis G, Gu X, Bailey C, Joseph M, Libermann TA, Schlossman R, Munshi NC, Hideshima T, Anderson KC. Mitsiades N, et al. Among authors: fanourakis g. Blood. 2003 Mar 15;101(6):2377-80. doi: 10.1182/blood-2002-06-1768. Epub 2002 Nov 7. Blood. 2003. PMID: 12424198 Free article.
Novel histone deacetylase inhibitors in the treatment of thyroid cancer.
Mitsiades CS, Poulaki V, McMullan C, Negri J, Fanourakis G, Goudopoulou A, Richon VM, Marks PA, Mitsiades N. Mitsiades CS, et al. Among authors: fanourakis g. Clin Cancer Res. 2005 May 15;11(10):3958-65. doi: 10.1158/1078-0432.CCR-03-0776. Clin Cancer Res. 2005. PMID: 15897598
Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation.
Mitsiades CS, Poulaki V, Fanourakis G, Sozopoulos E, McMillin D, Wen Z, Voutsinas G, Tseleni-Balafouta S, Mitsiades N. Mitsiades CS, et al. Among authors: fanourakis g. Clin Cancer Res. 2006 Jun 15;12(12):3705-12. doi: 10.1158/1078-0432.CCR-05-2493. Clin Cancer Res. 2006. PMID: 16778096
Targeting BRAFV600E in thyroid carcinoma: therapeutic implications.
Mitsiades CS, Negri J, McMullan C, McMillin DW, Sozopoulos E, Fanourakis G, Voutsinas G, Tseleni-Balafouta S, Poulaki V, Batt D, Mitsiades N. Mitsiades CS, et al. Among authors: fanourakis g. Mol Cancer Ther. 2007 Mar;6(3):1070-8. doi: 10.1158/1535-7163.MCT-06-0449. Mol Cancer Ther. 2007. PMID: 17363500
Molecular sequelae of histone deacetylase inhibition in human malignant B cells.
Mitsiades N, Mitsiades CS, Richardson PG, McMullan C, Poulaki V, Fanourakis G, Schlossman R, Chauhan D, Munshi NC, Hideshima T, Richon VM, Marks PA, Anderson KC. Mitsiades N, et al. Among authors: fanourakis g. Blood. 2003 May 15;101(10):4055-62. doi: 10.1182/blood-2002-11-3514. Epub 2003 Jan 16. Blood. 2003. PMID: 12531799 Free article.
63 results